Belgium· BE-AMP-SAM661702-00
Orkambi 75 mg - 94 mg
A ivacaftor and lumacaftor product containing lumacaftor, registered in Belgium by Vertex Pharmaceuticals (Ireland). The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ivacaftor and lumacaftor is registered in 16 of 19 countries.
Countries holding a registration under ATC R07AX30 (ivacaftor and lumacaftor), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Ivacaftor and lumacaftor · ATC R07AX30
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Lumacaftor
- Manufacturer
- Vertex Pharmaceuticals (Ireland)
- Country
- Belgium (BE)
- ATC code
- R07AX30
- ATC class
- Ivacaftor and lumacaftor
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R07AX30
Ivacaftor and lumacaftor, as other registers publish it.
- FinlandOrkambiVertex Pharmaceuticals (Ireland) Limited
- PolandOrkambiVertex Pharmaceuticals (Ireland) Ltd.
- IcelandOrkambiVertex Pharmaceuticals (Ireland) Limited
- FinlandOrkambiVertex Pharmaceuticals (Ireland) Limited
- FinlandOrkambiVertex Pharmaceuticals (Ireland) Limited
- FinlandOrkambiVertex Pharmaceuticals (Ireland) Limited
- FinlandOrkambiVertex Pharmaceuticals (Ireland) Limited
- PolandOrkambiVertex Pharmaceuticals (Ireland) Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da160f40-6907-4107-a427-ca61ef584545 GET /v1/drugs/da160f40-6907-4107-a427-ca61ef584545?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granules in sachet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Orkambi 75 mg - 94 mg",
"name_fr": "Orkambi 75 mg - 94 mg",
"name_nl": "Orkambi 75 mg - 94 mg",
"amp_code": "SAM661702-00",
"strengths": [
"75.0000",
"94.0000"
],
"pack_count": 1,
"substances": [
"Lumacaftor",
"Ivacaftor",
"Sodium Laurilsulfate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ivacaftor and Lumacaftor",
"authorisation_numbers": [
"EU/1/15/1059/008"
]
}See everything about ivacaftor and lumacaftor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.